Harold Frucht

4.1k total citations
61 papers, 3.2k citations indexed

About

Harold Frucht is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Harold Frucht has authored 61 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Harold Frucht's work include Pancreatic and Hepatic Oncology Research (15 papers), Cancer Genomics and Diagnostics (12 papers) and Neuroendocrine Tumor Research Advances (12 papers). Harold Frucht is often cited by papers focused on Pancreatic and Hepatic Oncology Research (15 papers), Cancer Genomics and Diagnostics (12 papers) and Neuroendocrine Tumor Research Advances (12 papers). Harold Frucht collaborates with scholars based in United States, United Kingdom and Canada. Harold Frucht's co-authors include Robert T. Jensen, Paul N. Maton, Rakesh Vinayek, Paula Calvert, Jerry D. Gardner, Alfred I. Neugut, Nicolle M. Gatto, Victor R. Grann, Judith S. Jacobson and Vijaya Sundararajan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Harold Frucht

61 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold Frucht United States 30 1.6k 1.2k 927 754 454 61 3.2k
Ming Lu China 28 1.4k 0.9× 701 0.6× 510 0.6× 951 1.3× 733 1.6× 140 3.0k
Yasunari Nakamoto Japan 35 1.4k 0.9× 1.1k 1.0× 1.2k 1.3× 280 0.4× 269 0.6× 191 4.5k
Hiromitsu Takeyama Japan 29 1.5k 1.0× 1.4k 1.2× 199 0.2× 665 0.9× 456 1.0× 152 3.5k
Motohiro Imano Japan 32 856 0.5× 1.1k 0.9× 247 0.3× 890 1.2× 913 2.0× 164 3.1k
Shingo Tsuji Japan 26 519 0.3× 1.1k 0.9× 460 0.5× 509 0.7× 369 0.8× 78 2.7k
Jan Axelson Sweden 24 712 0.4× 652 0.6× 374 0.4× 824 1.1× 221 0.5× 68 2.3k
José Palacios Spain 26 870 0.5× 1.5k 1.3× 365 0.4× 214 0.3× 288 0.6× 58 2.9k
Akira Yamanoi Japan 36 691 0.4× 1.0k 0.9× 985 1.1× 1.2k 1.6× 402 0.9× 85 4.0k
Fabrice Journé Belgium 35 1.1k 0.7× 1.4k 1.2× 123 0.1× 246 0.3× 353 0.8× 113 3.3k
James P. O’Brien United States 21 2.5k 1.6× 1.9k 1.6× 188 0.2× 458 0.6× 469 1.0× 37 4.6k

Countries citing papers authored by Harold Frucht

Since Specialization
Citations

This map shows the geographic impact of Harold Frucht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Frucht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Frucht more than expected).

Fields of papers citing papers by Harold Frucht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Frucht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Frucht. The network helps show where Harold Frucht may publish in the future.

Co-authorship network of co-authors of Harold Frucht

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Frucht. A scholar is included among the top collaborators of Harold Frucht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Frucht. Harold Frucht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassid, Benjamin, Aimee L. Lucas, Marcela Salomao, et al.. (2014). Absence of Pancreatic Intraepithelial Neoplasia Predicts Poor Survival After Resection of Pancreatic Cancer. Pancreas. 43(7). 1073–1077. 18 indexed citations
2.
Amin, Sunil, Aimee L. Lucas, & Harold Frucht. (2012). Evidence for Treatment and Survival Disparities by Age in Pancreatic Adenocarcinoma. Pancreas. 42(2). 249–253. 32 indexed citations
3.
Amin, Sunil, Russell B. McBride, Jennie Kline, et al.. (2011). Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers. Cancer. 118(5). 1244–1251. 17 indexed citations
4.
Vinarsky, Vladimir, Robert L. Fine, Adel Assaad, et al.. (2009). Head and neck squamous cell carcinoma in FAMMM syndrome. Head & Neck. 31(11). 1524–1527. 20 indexed citations
5.
Goldberg, Melvyn, Jeffrey M. Farma, Lawrence R. Coia, et al.. (2003). Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: A phase I report. Journal of Thoracic and Cardiovascular Surgery. 126(4). 1168–1173. 20 indexed citations
6.
Gatto, Nicolle M., Harold Frucht, Vijaya Sundararajan, et al.. (2003). Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study. JNCI Journal of the National Cancer Institute. 95(3). 230–236. 393 indexed citations
7.
Cheng, Kunrong, Ying Chen, Piotr Zimniak, et al.. (2002). Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(1). 48–55. 51 indexed citations
8.
Frucht, Harold, et al.. (1998). Functional expression of m3 muscarinic cholinergic receptors on human colon cancer cell lines. Gastroenterology. 114. A598–A598. 1 indexed citations
9.
O'Dwyer, P J, Christine E. Szarka, Kang-Shen Yao, et al.. (1996). Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.. Journal of Clinical Investigation. 98(5). 1210–1217. 73 indexed citations
10.
Mantey, Samuel A., et al.. (1993). Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: A comparative study. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1175(2). 232–242. 31 indexed citations
11.
Viallet, Jean, Yoav Sharoni, Harold Frucht, et al.. (1990). Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer.. Journal of Clinical Investigation. 86(6). 1904–1912. 28 indexed citations
12.
Miller, Larry S., Rakesh Vinayek, Harold Frucht, et al.. (1990). Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology. 98(2). 341–346. 114 indexed citations
13.
Frucht, Harold, Jeffrey A. Norton, Rakesh Vinayek, et al.. (1990). Detection of duodenal gastrinomas by operative endoscopic transillumination. Gastroenterology. 99(6). 1622–1627. 107 indexed citations
15.
Frucht, Harold, John M. Howard, Denis M. McCarthy, et al.. (1989). Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. The American Journal of Medicine. 87. 528–536. 1 indexed citations
16.
Frucht, Harold, et al.. (1989). Secretin and Calcium Provocative Tests in the Zollinger-Ellison Syndrome. Annals of Internal Medicine. 111(9). 713–722. 142 indexed citations
17.
Frucht, Harold, John M. Howard, Denis M. McCarthy, et al.. (1989). Prospective study of the standard meal provocative test in zollinger-ellison syndrome. The American Journal of Medicine. 87(5). 528–536. 16 indexed citations
18.
Maton, Paul N., Rakesh Vinayek, Harold Frucht, et al.. (1989). Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study. Gastroenterology. 97(4). 827–836. 109 indexed citations
19.
Maton, Paul N., Harold Frucht, Rakesh Vinayek, et al.. (1988). Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: A prospective study. Gastroenterology. 94(2). 294–299. 89 indexed citations
20.
Schrenck, T. von, John M. Howard, John L. Doppman, et al.. (1988). Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology. 94(6). 1326–1334. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026